The role of clinical imaging in oncological drug development. - Wikidata - wikimedia - TriplyDB

The role of clinical imaging in oncological drug development.

The role of clinical imaging in oncological drug development.

http://www.wikidata.org/entity/Q37187098

about

State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications.Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas Medical imaging in new drug clinical development.Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma.The impact of quantitative imaging in medicine and surgery: Charting our course for the future.Are the large pharmaceutical and biotechnology companies driving the discovery, research and development of targeted cancer therapies?Synthesis and Biological Evaluation of Novel 2-Aryl Benzimidazoles as Chemotherapeutic Agents

P2860

Q30928967-FCC43F29-057F-45C6-BEA4-A950414F9FC7 Q33517103-CA4F04BD-F759-41EC-BD59-6F6A106D7ACC Q34538659-6DA9A1EC-7D42-4AD0-B8A6-FA8BCB85C0BF Q34582022-3B71594E-A499-46EE-B684-A561235D915D Q35667744-FD0AAA74-1C0F-4044-BCB4-9479E80CF408 Q36054267-708C95E4-3CE3-409F-810B-428030CEF35B Q36394196-08713ABC-8593-4EAB-BA2F-94DA491B25C9 Q39675893-044E78E3-9808-4D83-86F8-3706D965D0C8 Q59166614-4C77CCA4-8479-47B8-ABCB-B0F9E7C20428

P2860

The role of clinical imaging in oncological drug development.

http://www.wikidata.org/entity/Q37187098

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of clinical imaging in oncological drug development.

@en

The role of clinical imaging in oncological drug development.

@nl

type

label

The role of clinical imaging in oncological drug development.

@en

The role of clinical imaging in oncological drug development.

@nl

prefLabel

The role of clinical imaging in oncological drug development.

@en

The role of clinical imaging in oncological drug development.

@nl

P1433

Q37187098-81FDC2BB-D48C-4017-A85F-E48E8866E1C6

P1476

Q37187098-345B84D8-72FF-40F3-A00B-8520875CB798

P2093

Q37187098-7A289A91-2076-43F6-8B1F-CEB13FC1F96D

Q37187098-AF4064B4-2CD1-4274-B05D-9A89A50D4856

Q37187098-CE6AB88A-C2D4-4E8F-81FD-CB476CD4EA0C

P2860

Q37187098-004E8182-F6DA-4741-A1F1-D1BC0E26C165

Q37187098-03890A2F-68E3-46BA-9E82-4737FE4F1A49

Q37187098-0702BF53-2CFF-4EAB-BDFC-99B1ED08436E

Q37187098-0D11A4D2-9825-4B16-93FB-7896B4B6A60B

Q37187098-0D199CBD-933D-4929-9CC6-9A6CF4651277

Q37187098-1099C02F-DC63-4645-9211-71FD35F1D9B4

Q37187098-14197F2F-42AD-45FA-B295-D82AC327B440

Q37187098-15D09F96-6E7F-4316-ADEB-052D5BE6DACA

Q37187098-15DE2BAD-D2DA-43A1-8F5B-671958F2E3D3

Q37187098-17AEFFC6-AB6D-413D-8680-2C9B1ED30A34

P304

Q37187098-2AFDDDCF-9148-4481-8AEC-25E7EB177190

P31

Q37187098-FAC9DCA6-C8A3-4CF3-BB83-A9A4906C9877

P356

Q37187098-AF31011D-125E-405F-A467-100484B914E9

P407

Q37187098-D78E4F71-884F-444C-966E-5298AB198009

P433

Q37187098-5BD872A9-4FA2-48CC-8A9F-ECEE5D83886C

P478

Q37187098-BF5B98D5-B79D-455E-AC75-129133C443BA

P577

Q37187098-64578C5B-7D4C-4B2B-9B59-D0694C9FBA21

P5875

Q37187098-B0C8F020-EC4A-4934-8433-1ECAF3463CF9

P698

Q37187098-358859EA-0156-4E86-8DF7-47F9372FA93A

P356

P1433

British Journal of Radiology

P1476

The role of clinical imaging in oncological drug development.

@en

P2093

A S K Dzik-Jurasz

http://www.w3.org/2001/XMLSchema#string

P S Murphy

http://www.w3.org/2001/XMLSchema#string

T J McCarthy

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

Can the pharmaceutical industry reduce attrition rates?

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Vessel size imaging.

Diffusion MRI for prediction of response of rectal cancer to chemoradiation.

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.

P304

685-692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR/16768437

http://www.w3.org/2001/XMLSchema#string

P407

P433

969

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5315045

http://www.w3.org/2001/XMLSchema#string

P698

18541632

http://www.w3.org/2001/XMLSchema#string